Drugs / EEA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07437053 | Jun 2026 → Jul 2027 expected | chronic kidney disease, muscular atrophy | The University of Texas Health Science Center at San Antonio | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07437053 ↗ |
| Route | Oral | “Daily oral consumption of 20 g essential amino acids (EAA)” NCT07437053 ↗ |